Page last updated: 2024-10-29

ketanserin and Anochlesia

ketanserin has been researched along with Anochlesia in 10 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Aripiprazole is a first next-generation atypical antipsychotic drug with dopamine system stabilizing, serotonin (5-hydroxytryptamine, 5-HT) 5-HT1A receptor partial agonistic, and 5-HT2A receptor antagonistic properties."1.35Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms. ( Abe, M; Egashira, N; Fujiwara, M; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Oishi, R; Okuno, R, 2008)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's5 (50.00)18.2507
2000's1 (10.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kołaczkowski, M1
Marcinkowska, M1
Bucki, A1
Pawłowski, M1
Mitka, K1
Jaśkowska, J1
Kowalski, P1
Kazek, G1
Siwek, A1
Wasik, A1
Wesołowska, A1
Mierzejewski, P1
Bienkowski, P1
Egashira, N1
Okuno, R1
Matsushita, M1
Abe, M1
Mishima, K1
Iwasaki, K1
Nishimura, R1
Oishi, R1
Fujiwara, M1
Creed-Carson, M1
Oraha, A1
Nobrega, JN1
Kulikov, AV2
Kolpakov, VG1
Maslova, GB1
Kozintsev, I1
Popova, NK2
Nucci-da-Silva, LP1
Guimarães, FS1
Del Bel, EA1
Barykina, NN1
Alekhina, TA1
Naumenko, KS1
Ninan, I1
Kulkarni, SK1
Hirose, A1
Kato, T1
Ohno, Y1
Shimizu, H1
Tanaka, H1
Nakamura, M1
Katsube, J1
Arnt, J2
Hyttel, J1
Bach-Lauritsen, T1

Other Studies

10 other studies available for ketanserin and Anochlesia

ArticleYear
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
    Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; C

2014
Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
    European journal of pharmacology, 2008, Sep-11, Volume: 592, Issue:1-3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavi

2008
Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats.
    Behavioural brain research, 2011, Jun-01, Volume: 219, Issue:2

    Topics: Aminopyridines; Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dyskinesia, Drug-Induced;

2011
Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.
    Psychopharmacology, 1994, Volume: 114, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Catalepsy; Dose-Response Relation

1994
Serotonin modulation of catalepsy induced by N(G)-nitro-L-arginine in mice.
    European journal of pharmacology, 1999, Aug-20, Volume: 379, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Bridged Bicyclo Compounds, Heterocyclic; Catalepsy; Dose-Resp

1999
[Effect of 5HT2 receptor blockade on the startle reflex and its prepulse inhibition in mice and rats of various strains].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 1999, Volume: 85, Issue:6

    Topics: Animals; Catalepsy; Cyproheptadine; Ketanserin; Mice; Mice, Inbred CBA; Rats; Rats, Wistar; Receptor

1999
Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Methods and findings in experimental and clinical pharmacology, 1999, Volume: 21, Issue:9

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Benzodiazepines; Catalepsy; C

1999
Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.
    Japanese journal of pharmacology, 1990, Volume: 53, Issue:3

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain Chemistry; Catalepsy; Dopamine Antagonists; I

1990
Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats.
    Acta pharmacologica et toxicologica, 1986, Volume: 59, Issue:4

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzamides; Benzazepines; Catalepsy; Dopamine Antag

1986
Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    European journal of pharmacology, 1985, Jul-11, Volume: 113, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal;

1985